About Bridgefield​

 

The team at Bridgefield possesses a 20+ year history of investing in distressed companies and generating superior risk adjusted investment returns.  Bridgefield focuses on opportunities across the corporate capital structure and across the distressed cycle to find investments with attractive risk reward ratios. The goal is to provide equity-like returns with credit-like risk and volatility in an uncorrelated fashion. 

The team at Bridgefield previously was with Ilex Capital Management.  Ilex was a distressed investment firm, primarily investing in distressed securities and corporate restructuring opportunities.  Ilex generated annual compounded returns of more than 30% from 2007 through 2013 before the firm was sold.  Ilex was a control investor within a number of leading international consumer product, manufacturing, and health care businesses including Gourmet Express, Calgon, and St. Joseph Healthcare among others.

Bridgefield invests capital on behalf of a diverse group of sophisticated institutions and individuals, including endowments, foundations, insurance companies, private banks, fund-of-funds, pensions, family offices and high net worth individuals.

Representative Investments

 

Questions? Comments?

Send us an email

 

info@bridgefieldcapital.com

 

Media Inquiries

media@bridgefieldcapital.com

 

 Human Resources

hresources@bridgefieldcapital.com

Contact Us

NEW YORK

230 Park Avenue

New York, NY 10017

212.634.9203

info@bridgefieldcapital.com

BRIDGEFIELD CAPITAL MANAGEMENT

THIS WEBSITE IS FOR INFORMATIONAL PURPOSES ONLY

IMPORTANT LEGAL TERMS & CONDITIONS >

© 2020 Bridgefield Capital Management

LONDON

14 Basil Street

Knightsbridge, London, SW3 1AJ 

44.203.868.1870

IR@bridgefieldcapital.com